Harvest Portfolios Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Harvest Portfolios Group's PFE Position: Q1 2026 in Review
Harvest Portfolios Group increased its Pfizer (PFE) stake by 16% in Q1 2026, buying an estimated $306K and bringing the position to 84,300 shares worth $2.37M. The position accounts for 0.04% of the portfolio, ranked #173.
Harvest Portfolios Group first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $49.7M in Q2 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Harvest Portfolios Group held 84,300 shares of Pfizer worth $2.37M as of Q1 2026.
- Harvest Portfolios Group bought 11,500 Pfizer shares in Q1 2026, an estimated $306K.
- Pfizer made up 0.04% of Harvest Portfolios Group's portfolio in Q1 2026, its #173 holding.
- Harvest Portfolios Group first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
- Harvest Portfolios Group's Pfizer position peaked at $49.7M in Q2 2023.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Harvest Portfolios Group's 13F filing for Q1 2026, filed 14 May 2026.